Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	neurohypophyseal hormone activity	OXT AVP	4.75e-06	2	44	2	GO:0005185
GeneOntologyMolecularFunction	V1A vasopressin receptor binding	OXT AVP	1.42e-05	3	44	2	GO:0031894
GeneOntologyMolecularFunction	vasopressin receptor binding	OXT AVP	2.84e-05	4	44	2	GO:0031893
GeneOntologyMolecularFunction	integrin binding	LAMB1 ESM1 ADAM23 ITGB2 ITGB7	4.02e-05	175	44	5	GO:0005178
GeneOntologyMolecularFunction	extracellular matrix structural constituent	LAMA2 LAMB1 COL6A3 MUC4 AGRN	5.66e-05	188	44	5	GO:0005201
GeneOntologyMolecularFunction	calcium ion binding	LRP1 DLK2 FAM20C EGFLAM PLCG1 CELSR3 AGRN NOTCH3	2.02e-04	749	44	8	GO:0005509
GeneOntologyMolecularFunction	histone H3 acetyltransferase activity	KAT2B BRD1	4.89e-04	15	44	2	GO:0010484
GeneOntologyMolecularFunction	heparan sulfate proteoglycan binding	LRP1 AGRN	1.86e-03	29	44	2	GO:0043395
GeneOntologyMolecularFunction	cell adhesion molecule binding	LAMB1 ESM1 ADAM23 ITGB2 ITGB7 NOTCH3	1.90e-03	599	44	6	GO:0050839
GeneOntologyMolecularFunction	laminin binding	NTN4 AGRN	2.55e-03	34	44	2	GO:0043236
GeneOntologyMolecularFunction	neuropeptide hormone activity	OXT AVP	2.55e-03	34	44	2	GO:0005184
GeneOntologyMolecularFunction	nuclear thyroid hormone receptor binding	NSD1 OASL	2.55e-03	34	44	2	GO:0046966
GeneOntologyMolecularFunction	neuropeptide activity	OXT AVP	2.55e-03	34	44	2	GO:0160041
GeneOntologyBiologicalProcess	axon guidance	LRP1 LAMA2 LAMB1 NTN4 CELSR3 FEZF2 AGRN NOTCH3	1.67e-07	285	45	8	GO:0007411
GeneOntologyBiologicalProcess	neuron projection guidance	LRP1 LAMA2 LAMB1 NTN4 CELSR3 FEZF2 AGRN NOTCH3	1.71e-07	286	45	8	GO:0097485
GeneOntologyBiologicalProcess	cell-substrate adhesion	PKHD1 LRP1 LAMB1 NTN4 EGFLAM MUC4 ITGB2 ITGB7	2.58e-06	410	45	8	GO:0031589
GeneOntologyBiologicalProcess	axonogenesis	LRP1 LAMA2 LAMB1 NTN4 CELSR3 FEZF2 AGRN NOTCH3	2.69e-05	566	45	8	GO:0007409
GeneOntologyBiologicalProcess	maternal aggressive behavior	OXT AVP	2.78e-05	4	45	2	GO:0002125
GeneOntologyBiologicalProcess	axon development	LRP1 LAMA2 LAMB1 NTN4 CELSR3 FEZF2 AGRN NOTCH3	6.57e-05	642	45	8	GO:0061564
GeneOntologyBiologicalProcess	basement membrane organization	LAMA2 LAMB1 NTN4	1.13e-04	43	45	3	GO:0071711
GeneOntologyBiologicalProcess	integrin-mediated signaling pathway	LAMA2 LAMB1 ITGB2 ITGB7	1.53e-04	124	45	4	GO:0007229
GeneOntologyBiologicalProcess	regulation of female receptivity	OXT AVP	1.66e-04	9	45	2	GO:0045924
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	LRP1 LAMA2 LAMB1 NTN4 CELSR3 FEZF2 AGRN NOTCH3	1.89e-04	748	45	8	GO:0048667
GeneOntologyBiologicalProcess	cell morphogenesis	PKHD1 LRP1 LAMA2 LAMB1 NTN4 CELSR3 FEZF2 ITGB2 AGRN NOTCH3	2.02e-04	1194	45	10	GO:0000902
GeneOntologyBiologicalProcess	regulation of basement membrane organization	LAMA2 LAMB1	2.53e-04	11	45	2	GO:0110011
GeneOntologyBiologicalProcess	cell maturation	NTN4 FAM20C BRD1 AGRN EPAS1	2.80e-04	267	45	5	GO:0048469
GeneOntologyBiologicalProcess	cell-matrix adhesion	PKHD1 LRP1 MUC4 ITGB2 ITGB7	2.95e-04	270	45	5	GO:0007160
GeneOntologyBiologicalProcess	female mating behavior	OXT AVP	3.03e-04	12	45	2	GO:0060180
GeneOntologyBiologicalProcess	basement membrane assembly	LAMB1 NTN4	3.03e-04	12	45	2	GO:0070831
GeneOntologyBiologicalProcess	regulation of axon guidance	FEZF2 AGRN	3.03e-04	12	45	2	GO:1902667
GeneOntologyBiologicalProcess	neuron projection morphogenesis	LRP1 LAMA2 LAMB1 NTN4 CELSR3 FEZF2 AGRN NOTCH3	3.03e-04	802	45	8	GO:0048812
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	LRP1 LAMA2 LAMB1 NTN4 CELSR3 FEZF2 AGRN NOTCH3	3.49e-04	819	45	8	GO:0120039
GeneOntologyBiologicalProcess	aggressive behavior	OXT AVP	3.58e-04	13	45	2	GO:0002118
GeneOntologyBiologicalProcess	cell projection morphogenesis	LRP1 LAMA2 LAMB1 NTN4 CELSR3 FEZF2 AGRN NOTCH3	3.70e-04	826	45	8	GO:0048858
GeneOntologyBiologicalProcess	positive regulation of integrin-mediated signaling pathway	LAMA2 LAMB1	4.17e-04	14	45	2	GO:2001046
GeneOntologyCellularComponent	basement membrane	LAMA2 LAMB1 NTN4 EGFLAM AGRN	6.32e-06	122	45	5	GO:0005604
GeneOntologyCellularComponent	protein complex involved in cell adhesion	LAMA2 LAMB1 ITGB2 ITGB7	7.82e-06	59	45	4	GO:0098636
GeneOntologyCellularComponent	synaptic cleft	LAMA2 EGFLAM AGRN	4.86e-05	33	45	3	GO:0043083
GeneOntologyCellularComponent	collagen-containing extracellular matrix	LAMA2 LAMB1 NTN4 COL6A3 EGFLAM MUC4 AGRN	1.27e-04	530	45	7	GO:0062023
GeneOntologyCellularComponent	laminin complex	LAMB1 NTN4	2.02e-04	10	45	2	GO:0043256
GeneOntologyCellularComponent	extracellular matrix	LAMA2 LAMB1 NTN4 COL6A3 EGFLAM MUC4 AGRN	4.67e-04	656	45	7	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	LAMA2 LAMB1 NTN4 COL6A3 EGFLAM MUC4 AGRN	4.75e-04	658	45	7	GO:0030312
GeneOntologyCellularComponent	protein complex involved in cell-matrix adhesion	LAMA2 LAMB1	6.04e-04	17	45	2	GO:0098637
GeneOntologyCellularComponent	integrin complex	ITGB2 ITGB7	2.16e-03	32	45	2	GO:0008305
GeneOntologyCellularComponent	cell surface	PKHD1 LRP1 PRSS8 KISS1R ITGB2 AGRN ITGB7 NOTCH3	2.31e-03	1111	45	8	GO:0009986
GeneOntologyCellularComponent	axonal growth cone	LRP1 AGRN	4.23e-03	45	45	2	GO:0044295
GeneOntologyCellularComponent	postsynaptic density membrane	LRP1 GSG1L CELSR3	4.68e-03	157	45	3	GO:0098839
GeneOntologyCellularComponent	endoplasmic reticulum lumen	LAMB1 COL6A3 FAM20C SUMF1	5.58e-03	332	45	4	GO:0005788
MousePheno	myopathy	LAMA2 COL6A3 AGRN NOTCH3	1.64e-05	54	40	4	MP:0000751
Domain	EGF_1	LRP1 DLK2 LAMA2 LAMB1 NTN4 EGFLAM CELSR3 ADAM23 MUC4 ITGB2 AGRN ITGB7 NOTCH3 PEAR1	6.26e-16	255	45	14	PS00022
Domain	EGF-like_CS	LRP1 DLK2 LAMA2 LAMB1 NTN4 EGFLAM CELSR3 ADAM23 MUC4 ITGB2 AGRN ITGB7 NOTCH3 PEAR1	8.66e-16	261	45	14	IPR013032
Domain	EGF_2	LRP1 DLK2 LAMA2 LAMB1 EGFLAM CELSR3 ADAM23 MUC4 ITGB2 AGRN ITGB7 NOTCH3 PEAR1	3.43e-14	265	45	13	PS01186
Domain	EGF	LRP1 DLK2 LAMA2 LAMB1 EGFLAM CELSR3 ADAM23 MUC4 AGRN NOTCH3 PEAR1	6.90e-12	235	45	11	SM00181
Domain	EGF-like_dom	LRP1 DLK2 LAMA2 LAMB1 EGFLAM CELSR3 ADAM23 MUC4 AGRN NOTCH3 PEAR1	1.29e-11	249	45	11	IPR000742
Domain	Laminin_EGF	LAMA2 LAMB1 NTN4 CELSR3 AGRN PEAR1	2.13e-10	35	45	6	PF00053
Domain	EGF_Lam	LAMA2 LAMB1 NTN4 CELSR3 AGRN PEAR1	2.13e-10	35	45	6	SM00180
Domain	Laminin_EGF	LAMA2 LAMB1 NTN4 CELSR3 AGRN PEAR1	3.60e-10	38	45	6	IPR002049
Domain	EGF_3	LRP1 DLK2 EGFLAM CELSR3 ADAM23 MUC4 AGRN NOTCH3 PEAR1	4.05e-09	235	45	9	PS50026
Domain	EGF_LAM_2	LAMA2 LAMB1 NTN4 CELSR3 AGRN	8.80e-09	30	45	5	PS50027
Domain	EGF_LAM_1	LAMA2 LAMB1 NTN4 CELSR3 AGRN	8.80e-09	30	45	5	PS01248
Domain	EGF	LRP1 DLK2 EGFLAM CELSR3 MUC4 AGRN NOTCH3	1.97e-08	126	45	7	PF00008
Domain	EGF_extracell	DLK2 ADAM23 ITGB2 ITGB7 NOTCH3	3.20e-07	60	45	5	IPR013111
Domain	EGF_2	DLK2 ADAM23 ITGB2 ITGB7 NOTCH3	3.20e-07	60	45	5	PF07974
Domain	EGF_CA	LRP1 DLK2 EGFLAM CELSR3 AGRN NOTCH3	4.54e-07	122	45	6	SM00179
Domain	EGF-like_Ca-bd_dom	LRP1 DLK2 EGFLAM CELSR3 AGRN NOTCH3	5.00e-07	124	45	6	IPR001881
Domain	LAM_G_DOMAIN	LAMA2 EGFLAM CELSR3 AGRN	2.04e-06	38	45	4	PS50025
Domain	Laminin_G_1	LAMA2 EGFLAM AGRN	2.13e-06	11	45	3	PF00054
Domain	LamG	LAMA2 EGFLAM CELSR3 AGRN	3.72e-06	44	45	4	SM00282
Domain	Neurhyp_horm	OXT AVP	5.68e-06	2	45	2	PD001676
Domain	Neurohypophysial_hormone_CS	OXT AVP	5.68e-06	2	45	2	IPR022423
Domain	Hormone_4	OXT AVP	5.68e-06	2	45	2	PF00220
Domain	Hormone_5	OXT AVP	5.68e-06	2	45	2	PF00184
Domain	-	OXT AVP	5.68e-06	2	45	2	2.60.9.10
Domain	NEUROHYPOPHYS_HORM	OXT AVP	5.68e-06	2	45	2	PS00264
Domain	NH	OXT AVP	5.68e-06	2	45	2	SM00003
Domain	Laminin_N	LAMA2 LAMB1 NTN4	7.16e-06	16	45	3	IPR008211
Domain	LAMININ_NTER	LAMA2 LAMB1 NTN4	7.16e-06	16	45	3	PS51117
Domain	Laminin_N	LAMA2 LAMB1 NTN4	7.16e-06	16	45	3	PF00055
Domain	LamNT	LAMA2 LAMB1 NTN4	7.16e-06	16	45	3	SM00136
Domain	Laminin_G	LAMA2 EGFLAM CELSR3 AGRN	1.13e-05	58	45	4	IPR001791
Domain	PWWP	NSD1 BRD1 DNMT3A	1.45e-05	20	45	3	SM00293
Domain	PWWP	NSD1 BRD1 DNMT3A	2.24e-05	23	45	3	PF00855
Domain	PWWP_dom	NSD1 BRD1 DNMT3A	2.24e-05	23	45	3	IPR000313
Domain	PWWP	NSD1 BRD1 DNMT3A	2.55e-05	24	45	3	PS50812
Domain	Neurhyp_horm	OXT AVP	3.40e-05	4	45	2	IPR000981
Domain	Growth_fac_rcpt_	LRP1 LAMB1 ESM1 NTN4 NOTCH3	3.56e-05	156	45	5	IPR009030
Domain	-	LAMA2 EGFLAM CELSR3 AGRN	7.98e-05	95	45	4	2.60.120.200
Domain	Integrin_bsu_cyt_dom	ITGB2 ITGB7	8.46e-05	6	45	2	IPR014836
Domain	Integrin_b_cyt	ITGB2 ITGB7	8.46e-05	6	45	2	SM01241
Domain	Integrin_b_cyt	ITGB2 ITGB7	8.46e-05	6	45	2	PF08725
Domain	ASX_HYDROXYL	LRP1 DLK2 CELSR3 NOTCH3	9.74e-05	100	45	4	PS00010
Domain	Integrin_bsu_tail	ITGB2 ITGB7	1.18e-04	7	45	2	IPR012896
Domain	Integrin_B_tail	ITGB2 ITGB7	1.18e-04	7	45	2	SM01242
Domain	Integrin_B_tail	ITGB2 ITGB7	1.18e-04	7	45	2	PF07965
Domain	Laminin_G_2	LAMA2 EGFLAM CELSR3	1.21e-04	40	45	3	PF02210
Domain	EGF-type_Asp/Asn_hydroxyl_site	LRP1 DLK2 CELSR3 NOTCH3	1.22e-04	106	45	4	IPR000152
Domain	Integrin_beta	ITGB2 ITGB7	1.57e-04	8	45	2	PF00362
Domain	INB	ITGB2 ITGB7	1.57e-04	8	45	2	SM00187
Domain	Integrin_bsu_VWA	ITGB2 ITGB7	1.57e-04	8	45	2	IPR002369
Domain	Integrin_bsu	ITGB2 ITGB7	2.02e-04	9	45	2	IPR015812
Domain	Integin_beta_N	ITGB2 ITGB7	2.02e-04	9	45	2	IPR033760
Domain	INTEGRIN_BETA	ITGB2 ITGB7	2.02e-04	9	45	2	PS00243
Domain	PSI_integrin	ITGB2 ITGB7	2.02e-04	9	45	2	PF17205
Domain	-	COL6A3 ITGB2 ITGB7	7.52e-04	74	45	3	3.40.50.410
Domain	VWFA	COL6A3 ITGB2 ITGB7	1.01e-03	82	45	3	PS50234
Domain	VWA	COL6A3 ITGB2 ITGB7	1.09e-03	84	45	3	SM00327
Domain	Galactose-bd-like	LAMA2 LAMB1 NTN4	1.50e-03	94	45	3	IPR008979
Domain	Integrin_dom	ITGB2 ITGB7	1.64e-03	25	45	2	IPR032695
Domain	EGF_Ca-bd_CS	LRP1 DLK2 NOTCH3	1.65e-03	97	45	3	IPR018097
Domain	EGF_CA	LRP1 DLK2 NOTCH3	1.74e-03	99	45	3	PS01187
Domain	VWF_A	COL6A3 ITGB2 ITGB7	1.74e-03	99	45	3	IPR002035
Domain	Bromodomain_CS	KAT2B BRD1	1.78e-03	26	45	2	IPR018359
Domain	TIMP-like_OB-fold	NTN4 AGRN	1.78e-03	26	45	2	IPR008993
Domain	ConA-like_dom	LAMA2 EGFLAM CELSR3 AGRN	1.88e-03	219	45	4	IPR013320
Domain	hEGF	DLK2 NOTCH3	2.06e-03	28	45	2	PF12661
Domain	BROMODOMAIN_1	KAT2B BRD1	3.58e-03	37	45	2	PS00633
Domain	Bromodomain	KAT2B BRD1	3.78e-03	38	45	2	PF00439
Domain	BROMODOMAIN_2	KAT2B BRD1	4.38e-03	41	45	2	PS50014
Domain	BROMO	KAT2B BRD1	4.60e-03	42	45	2	SM00297
Domain	Bromodomain	KAT2B BRD1	4.60e-03	42	45	2	IPR001487
Domain	-	KAT2B BRD1	4.60e-03	42	45	2	1.20.920.10
Pathway	KEGG_ECM_RECEPTOR_INTERACTION	LAMA2 LAMB1 COL6A3 AGRN ITGB7	1.62e-06	84	34	5	M7098
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	LAMA2 LAMB1 NTN4 COL6A3 ITGB2 AGRN ITGB7	6.05e-06	300	34	7	M610
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	LAMA2 LAMB1 NTN4 AGRN	1.17e-05	59	34	4	M27218
Pathway	REACTOME_ECM_PROTEOGLYCANS	LAMA2 LAMB1 COL6A3 AGRN	3.20e-05	76	34	4	M27219
Pathway	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	COL6A3 ITGB2 AGRN ITGB7	4.97e-05	85	34	4	M16441
Pathway	REACTOME_VASOPRESSIN_LIKE_RECEPTORS	OXT AVP	8.42e-05	6	34	2	M27289
Pathway	REACTOME_VASOPRESSIN_LIKE_RECEPTORS	OXT AVP	8.42e-05	6	34	2	MM14989
Pathway	PID_INTEGRIN4_PATHWAY	LAMA2 LAMB1	3.06e-04	11	34	2	M158
Pathway	PID_INTEGRIN1_PATHWAY	LAMA2 LAMB1 COL6A3	5.29e-04	66	34	3	M18
Pubmed	Transcriptome-based systematic identification of extracellular matrix proteins.	LAMA2 LAMB1 NTN4 EGFLAM AGRN	7.57e-08	79	47	5	18757743
Pubmed	Functional analysis of secreted and transmembrane proteins critical to mouse development.	LAMB1 ADAM23 AGRN NOTCH3	8.97e-08	31	47	4	11431694
Pubmed	Defining brain wiring patterns and mechanisms through gene trapping in mice.	LAMB1 ADAM23 NOTCH3	8.33e-07	14	47	3	11242070
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	LAMA2 LAMB1 COL6A3 AGRN	1.75e-06	64	47	4	22261194
Pubmed	Vasopressin and oxytocin excite MCH neurons, but not other lateral hypothalamic GABA neurons.	OXT AVP	1.79e-06	2	47	2	22262306
Pubmed	The neurohypophyseal hormones vasopressin and oxytocin. Precursor structure, synthesis and regulation.	OXT AVP	1.79e-06	2	47	2	3768139
Pubmed	Expression of the vasopressin and oxytocin genes in human hypothalami.	OXT AVP	1.79e-06	2	47	2	4065330
Pubmed	The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line.	OXT AVP	1.79e-06	2	47	2	2991279
Pubmed	Associations of oxytocin and vasopressin plasma levels with neurocognitive, social cognitive and meta cognitive function in schizophrenia.	OXT AVP	1.79e-06	2	47	2	29609987
Pubmed	A systematic survey of the intergenic region between the murine oxytocin- and vasopressin-encoding genes.	OXT AVP	1.79e-06	2	47	2	8863731
Pubmed	LDL-receptor-related protein regulates beta2-integrin-mediated leukocyte adhesion.	LRP1 ITGB2	1.79e-06	2	47	2	15328156
Pubmed	Vasopressin and oxytocin in CSF and plasma of patients with aneurysmal subarachnoid haemorrhage.	OXT AVP	1.79e-06	2	47	2	24412107
Pubmed	Synthesis, transport, and release of posterior pituitary hormones.	OXT AVP	1.79e-06	2	47	2	6153132
Pubmed	COL6A and LAMA2 Mutation Congenital Muscular Dystrophy: A Clinical and Electrophysiological Study.	LAMA2 COL6A3	1.79e-06	2	47	2	29465610
Pubmed	The contributions of oxytocin and vasopressin pathway genes to human behavior.	OXT AVP	1.79e-06	2	47	2	22245314
Pubmed	Mothers of autistic children: lower plasma levels of oxytocin and Arg-vasopressin and a higher level of testosterone.	OXT AVP	1.79e-06	2	47	2	24086383
Pubmed	Influence of perioperative stress on central and peripheral oxytocin and arginine-vasopressin concentrations.	OXT AVP	1.79e-06	2	47	2	31538678
Pubmed	Oxytocin and vasopressin: social neuropeptides with complex neuromodulatory functions.	OXT AVP	1.79e-06	2	47	2	23589638
Pubmed	[Oxytocin and vasopressin: sexual differences and clinical implications].	OXT AVP	1.79e-06	2	47	2	37200960
Pubmed	Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree.	OXT AVP	1.79e-06	2	47	2	21899794
Pubmed	On the nature of oxytocin and vasopressin from human pituitary.	OXT AVP	1.79e-06	2	47	2	13591312
Pubmed	Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin.	LAMA2 AGRN	1.79e-06	2	47	2	16103356
Pubmed	Marital behavior, oxytocin, vasopressin, and wound healing.	OXT AVP	1.79e-06	2	47	2	20144509
Pubmed	Medial amygdala lesions modify aggressive behavior and immediate early gene expression in oxytocin and vasopressin neurons during intermale exposure.	OXT AVP	1.79e-06	2	47	2	23403283
Pubmed	Expression of the arginine vasopressin gene in response to salt loading in oxytocin gene knockout mice.	OXT AVP	1.79e-06	2	47	2	14962074
Pubmed	Agrin binds to the nerve-muscle basal lamina via laminin.	LAMB1 AGRN	1.79e-06	2	47	2	9151673
Pubmed	Regulatory domains in the intergenic region of the oxytocin and vasopressin genes that control their hypothalamus-specific expression in vitro.	OXT AVP	1.79e-06	2	47	2	12944509
Pubmed	Hypothalamic vasopressin and oxytocin mRNA expression in relation to depressive state in Alzheimer's disease: a difference with major depressive disorder.	OXT AVP	1.79e-06	2	47	2	19500216
Pubmed	Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome.	OXT AVP	1.79e-06	2	47	2	36113782
Pubmed	Defensive behavioral strategies and enhanced state anxiety during chronic subordinate colony housing are accompanied by reduced hypothalamic vasopressin, but not oxytocin, expression.	OXT AVP	1.79e-06	2	47	2	19120108
Pubmed	The Role of Oxytocin and Vasopressin in Drug-Induced Reward-Implications for Social and Non-Social Factors.	OXT AVP	1.79e-06	2	47	2	36979340
Pubmed	Identification of human neurophysins: complete amino acid sequences of MSEL- and VLDV-neurophysins.	OXT AVP	1.79e-06	2	47	2	6574452
Pubmed	Ontogeny of the vasopressin and oxytocin RNAs in the mouse hypothalamus.	OXT AVP	1.79e-06	2	47	2	9678638
Pubmed	Sociality, pathogen avoidance, and the neuropeptides oxytocin and arginine vasopressin.	OXT AVP	1.79e-06	2	47	2	21960250
Pubmed	Comparison of vasopressin and oxytocin expressions in the hypothalamo-neurohypophysial system of patients with chronic heart failure.	OXT AVP	1.79e-06	2	47	2	19672816
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	LAMA2 LAMB1 COL6A3 MUC4 AGRN	3.94e-06	175	47	5	28071719
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	PPP1R3D GSX2 PLCG1 OXT CELSR3 NOTCH3	5.30e-06	329	47	6	17474147
Pubmed	Hematopoietic stem/progenitor cells directly contribute to arteriosclerotic progression via integrin β2.	LRP1 ITGB2	5.36e-06	3	47	2	25546260
Pubmed	Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1.	ESM1 ITGB2	5.36e-06	3	47	2	11544294
Pubmed	Plasma concentrations of peptide hormones: Unrealistic levels of vasopressin (AVP), oxytocin (OXT), and brain natriuretic peptide (BNP).	OXT AVP	5.36e-06	3	47	2	39034759
Pubmed	Characterization and expression of the laminin gamma3 chain: a novel, non-basement membrane-associated, laminin chain.	LAMA2 LAMB1	5.36e-06	3	47	2	10225960
Pubmed	Low density lipoprotein receptor-related protein-1 (LRP1) regulates thrombospondin-2 (TSP2) enhancement of Notch3 signaling.	LRP1 NOTCH3	5.36e-06	3	47	2	20472562
Pubmed	Increased aggression and lack of maternal behavior in Dio3-deficient mice are associated with abnormalities in oxytocin and vasopressin systems.	OXT AVP	5.36e-06	3	47	2	28715127
Pubmed	Specification of oxytocinergic and vasopressinergic circuits in the developing mouse brain.	OXT AVP	5.36e-06	3	47	2	33990685
Pubmed	Molecular basis for the interaction of low density lipoprotein receptor-related protein 1 (LRP1) with integrin alphaMbeta2: identification of binding sites within alphaMbeta2 for LRP1.	LRP1 ITGB2	5.36e-06	3	47	2	21676865
Pubmed	G9a-Mediated Regulation of OXT and AVP Expression in the Basolateral Amygdala Mediates Stress-Induced Lasting Behavioral Depression and Its Reversal by Exercise.	OXT AVP	5.36e-06	3	47	2	25863961
Pubmed	Structure of mouse vasopressin and oxytocin genes.	OXT AVP	5.36e-06	3	47	2	2176709
Pubmed	Estrogen receptor-beta regulates transcript levels for oxytocin and arginine vasopressin in the hypothalamic paraventricular nucleus of male mice.	OXT AVP	5.36e-06	3	47	2	12531518
Pubmed	Basement membrane assembly of the integrin α8β1 ligand nephronectin requires Fraser syndrome-associated proteins.	LAMA2 LAMB1 AGRN	8.25e-06	29	47	3	22613833
Pubmed	Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.	LAMA2 LAMB1 COL6A3 AGRN	9.25e-06	97	47	4	27559042
Pubmed	A distinct hypothalamus-to-β cell circuit modulates insulin secretion.	OXT AVP	1.07e-05	4	47	2	35108515
Pubmed	Identification of a neurocircuit underlying regulation of feeding by stress-related emotional responses.	OXT AVP	1.07e-05	4	47	2	31371721
Pubmed	Laminin alpha 1, alpha 2, alpha 4 and beta 1 chain mRNA expression in mouse embryonic, neonatal, and adult hearts.	LAMA2 LAMB1	1.07e-05	4	47	2	9201115
Pubmed	Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids.	OXT AVP	1.07e-05	4	47	2	11089561
Pubmed	Organisation of extracellular matrix proteins laminin and agrin in pericapillary basal laminae in mouse brain.	LAMA2 AGRN	1.07e-05	4	47	2	32072250
Pubmed	Impact of Sim1 gene dosage on the development of the paraventricular and supraoptic nuclei of the hypothalamus.	OXT AVP	1.07e-05	4	47	2	20092567
Pubmed	β1- and αv-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments.	ITGB2 ITGB7	1.07e-05	4	47	2	23708002
Pubmed	Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits.	LAMA2 LAMB1	1.07e-05	4	47	2	2099832
Pubmed	Complement receptor 3 (CD11b/CD18) is implicated in the elimination of β-amyloid peptides.	LRP1 ITGB2	1.07e-05	4	47	2	20199584
Pubmed	Oxytocin, vasopressin and estrogen receptor gene expression in relation to social recognition in female mice.	OXT AVP	1.07e-05	4	47	2	22079582
Pubmed	Differential molecular and anatomical basis for B cell migration into the peritoneal cavity and omental milky spots.	ITGB2 ITGB7	1.07e-05	4	47	2	18250426
Pubmed	Rap1-mediated lymphocyte function-associated antigen-1 activation by the T cell antigen receptor is dependent on phospholipase C-gamma1.	PLCG1 ITGB2	1.07e-05	4	47	2	14702343
Pubmed	An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.	LAMA2 AGRN	1.07e-05	4	47	2	11565031
Pubmed	Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins.	LRP1 ITGB2 ITGB7 NOTCH3	1.09e-05	101	47	4	23382219
Pubmed	Oxytocin-Gly-Lys-Arg: a novel cardiomyogenic peptide.	OXT AVP	1.78e-05	5	47	2	21048978
Pubmed	CAPS2 Deficiency Impairs the Release of the Social Peptide Oxytocin, as Well as Oxytocin-Associated Social Behavior.	OXT AVP	1.78e-05	5	47	2	33846232
Pubmed	Birth elicits a conserved neuroendocrine response with implications for perinatal osmoregulation and neuronal cell death.	OXT AVP	1.78e-05	5	47	2	33504846
Pubmed	Role of the hepatocyte nuclear factor-1beta (HNF-1beta) C-terminal domain in Pkhd1 (ARPKD) gene transcription and renal cystogenesis.	PKHD1 KAT2B	1.78e-05	5	47	2	15647252
Pubmed	A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene.	OXT AVP	1.78e-05	5	47	2	20876615
Pubmed	Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo.	LAMA2 LAMB1	1.78e-05	5	47	2	8719886
Pubmed	Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need.	OXT AVP	1.78e-05	5	47	2	7830793
Pubmed	Laminin 211 inhibits protein kinase A in Schwann cells to modulate neuregulin 1 type III-driven myelination.	LAMA2 LAMB1	1.78e-05	5	47	2	28636612
Pubmed	Identification and characterization of multiple similar ligand-binding repeats in filamin: implication on filamin-mediated receptor clustering and cross-talk.	ITGB2 ITGB7	1.78e-05	5	47	2	19828450
Pubmed	The pituitary hormones arginine vasopressin-neurophysin II and oxytocin-neurophysin I show close linkage with interleukin-1 on mouse chromosome 2.	OXT AVP	1.78e-05	5	47	2	8432536
Pubmed	Laminin alpha 2 chain (M chain) is found within the pathway of avian and murine retinal projections.	LAMA2 LAMB1	1.78e-05	5	47	2	8613743
Pubmed	Thyroid follicle development requires Smad1/5- and endothelial cell-dependent basement membrane assembly.	LAMA2 LAMB1 ESM1	2.21e-05	40	47	3	27068110
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	LRP1 LAMA2 LAMB1 COL6A3 ITGB2	2.52e-05	257	47	5	16335952
Pubmed	Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization.	LAMA2 LAMB1	2.67e-05	6	47	2	1678389
Pubmed	Biased Oxytocinergic Modulation of Midbrain Dopamine Systems.	OXT AVP	2.67e-05	6	47	2	28669546
Pubmed	Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution.	LAMA2 LAMB1	2.67e-05	6	47	2	23948589
Pubmed	Threonine phosphorylation sites in the beta 2 and beta 7 leukocyte integrin polypeptides.	ITGB2 ITGB7	2.67e-05	6	47	2	12682249
Pubmed	Entactin: structure and function.	LAMA2 LAMB1	2.67e-05	6	47	2	2119632
Pubmed	The origin of the ankyrin repeat region in Notch intracellular domains is critical for regulation of HES promoter activity.	KAT2B NOTCH3	2.67e-05	6	47	2	11404076
Pubmed	Defective development of secretory neurones in the hypothalamus of Arnt2-knockout mice.	OXT AVP	2.67e-05	6	47	2	11318878
Pubmed	A functional role for circulating mouse L-selectin in regulating leukocyte/endothelial cell interactions in vivo.	ITGB2 ITGB7	2.67e-05	6	47	2	12165530
Pubmed	Light modulates glucose metabolism by a retina-hypothalamus-brown adipose tissue axis.	OXT AVP	2.67e-05	6	47	2	36669474
Pubmed	Integrins as receptors for laminins.	LAMA2 LAMB1	2.67e-05	6	47	2	11054877
Pubmed	Cytohesin-1 controls the activation of RhoA and modulates integrin-dependent adhesion and migration of dendritic cells.	ITGB2 ITGB7	2.67e-05	6	47	2	19346499
Pubmed	Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations.	ITGB2 ITGB7	2.67e-05	6	47	2	24829201
Pubmed	Gating of social reward by oxytocin in the ventral tegmental area.	OXT AVP	2.67e-05	6	47	2	28963257
Pubmed	Functional circuit architecture underlying parental behaviour.	OXT AVP	2.67e-05	6	47	2	29643503
Pubmed	Impaired primary mouse myotube formation on crosslinked type I collagen films is enhanced by laminin and entactin.	LAMA2 LAMB1	2.67e-05	6	47	2	26555376
Pubmed	Rapid leukocyte migration by integrin-independent flowing and squeezing.	ITGB2 ITGB7	2.67e-05	6	47	2	18451854
Pubmed	Effect of basement membrane entactin on epidermal cell attachment and growth.	LAMA2 LAMB1	2.67e-05	6	47	2	3794389
Pubmed	Laminin-nidogen complex. Extraction with chelating agents and structural characterization.	LAMA2 LAMB1	2.67e-05	6	47	2	3109910
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	LAMA2 LAMB1 COL6A3 AGRN	3.40e-05	135	47	4	28675934
Pubmed	Identification and characterization of TRP14, a thioredoxin-related protein of 14 kDa. New insights into the specificity of thioredoxin function.	OXT AVP	3.74e-05	7	47	2	14607844
Pubmed	The human WD repeat protein WAIT-1 specifically interacts with the cytoplasmic tails of beta7-integrins.	ITGB2 ITGB7	3.74e-05	7	47	2	9765275
Pubmed	Inflammatory macrophages exploit unconventional pro-phagocytic integrins for phagocytosis and anti-tumor immunity.	LRP1 ITGB2	3.74e-05	7	47	2	34910922
Pubmed	Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor.	LAMA2 LAMB1	3.74e-05	7	47	2	9004048
Interaction	MANEA interactions	LAMB1 TMEM30B AGRN ITGB7	9.65e-06	60	45	4	int:MANEA
Interaction	NR6A1 interactions	NSD1 EPAS1 DNMT3A	2.04e-05	24	45	3	int:NR6A1
GeneFamily	PWWP domain containing	NSD1 BRD1 DNMT3A	7.58e-06	22	32	3	1147
GeneFamily	CD molecules\|Integrin beta subunits	ITGB2 ITGB7	1.08e-04	9	32	2	1159
GeneFamily	Laminin subunits	LAMA2 LAMB1	1.98e-04	12	32	2	626
Coexpression	NABA_BASEMENT_MEMBRANES	LAMA2 LAMB1 NTN4 COL6A3 AGRN	8.36e-09	40	46	5	M5887
Coexpression	RELA_DN.V1_DN	PRSS8 OXT AVP MUC4 TFF1 DNMT3A	1.57e-07	139	46	6	M2695
Coexpression	CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP	LAMB1 ESM1 COL6A3 PLCG1 NOTCH3 DNMT3A	3.88e-07	162	46	6	M45037
Coexpression	NABA_CORE_MATRISOME	LAMA2 LAMB1 ESM1 NTN4 COL6A3 EGFLAM AGRN	4.32e-07	270	46	7	MM17057
Coexpression	NABA_CORE_MATRISOME	LAMA2 LAMB1 ESM1 NTN4 COL6A3 EGFLAM AGRN	4.89e-07	275	46	7	M5884
Coexpression	LEE_BMP2_TARGETS_UP	LRP1 LAMA2 TMEM30B NTN4 FAM20C EGFLAM PRSS8 TBC1D4 AGRN NOTCH3	7.95e-07	780	46	10	M2324
Coexpression	LEE_BMP2_TARGETS_UP	LRP1 LAMA2 TMEM30B NTN4 FAM20C EGFLAM PRSS8 TBC1D4 AGRN NOTCH3	1.06e-06	805	46	10	MM1067
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE	EGFLAM AGRN EPAS1 NOTCH3 PEAR1 PDZD2	1.15e-06	195	46	6	M45684
Coexpression	VERRECCHIA_RESPONSE_TO_TGFB1_C2	LRP1 COL6A3 ITGB2	6.58e-06	21	46	3	M4767
Coexpression	NABA_MATRISOME	LAMA2 LAMB1 ESM1 NTN4 COL6A3 FAM20C EGFLAM ADAM23 MUC4 AGRN	7.82e-06	1008	46	10	MM17056
Coexpression	NABA_MATRISOME	LAMA2 LAMB1 ESM1 NTN4 COL6A3 FAM20C EGFLAM ADAM23 MUC4 AGRN	9.13e-06	1026	46	10	M5889
Coexpression	FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2	LAMA2 LAMB1 AGRN EPAS1 NOTCH3 PDZD2	1.44e-05	303	46	6	M39040
Coexpression	BENPORATH_ES_WITH_H3K27ME3	DLK2 LAMB1 TMEM30B GSX2 EGFLAM KISS1R FEZF2 MMD2 EPAS1 PDZD2	1.88e-05	1115	46	10	M10371
Coexpression	NABA_ECM_GLYCOPROTEINS	LAMA2 LAMB1 NTN4 EGFLAM AGRN	2.10e-05	191	46	5	MM17059
Coexpression	NABA_ECM_GLYCOPROTEINS	LAMA2 LAMB1 NTN4 EGFLAM AGRN	2.37e-05	196	46	5	M3008
Coexpression	FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL	LAMA2 LAMB1 AGRN EPAS1 NOTCH3 PDZD2	4.10e-05	365	46	6	M39018
Coexpression	TRAVAGLINI_LUNG_PERICYTE_CELL	LAMB1 NOTCH3 PEAR1 PDZD2	4.81e-05	114	46	4	M41678
Coexpression	WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	LAMA2 COL6A3 ITGB2	1.05e-04	52	46	3	M19766
Coexpression	MARTENS_TRETINOIN_RESPONSE_UP	GSX2 FAM20C FEZF2 MUC4 ITGB2 NOTCH3 TFF1 ZDHHC22	1.08e-04	855	46	8	M2098
Coexpression	KRAS.PROSTATE_UP.V1_DN	OXT ADAM23 MUC4 ITGB7	1.10e-04	141	46	4	M2901
Coexpression	VERRECCHIA_EARLY_RESPONSE_TO_TGFB1	LRP1 COL6A3 ITGB2	1.18e-04	54	46	3	M4737
Coexpression	GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS	LRP1 COL6A3 FAM20C EGFLAM NOTCH3 PEAR1	2.42e-04	505	46	6	M39167
Coexpression	HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN	LRP1 NTN4 COL6A3 KISS1R ITGB2 SUMF1 NOTCH3	2.85e-04	740	46	7	M41202
Coexpression	LEE_AGING_NEOCORTEX_UP	LAMB1 OXT AVP	3.38e-04	77	46	3	M1590
Coexpression	GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN	PRSS8 AVP EPAS1 OASL	3.58e-04	192	46	4	M8195
Coexpression	AIZARANI_LIVER_C21_STELLATE_CELLS_1	LRP1 LAMB1 COL6A3 EPAS1	3.72e-04	194	46	4	M39122
Coexpression	GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_DN	CHPF2 KISS1R EPAS1 NOTCH3	3.95e-04	197	46	4	M6152
Coexpression	GSE4142_NAIVE_VS_GC_BCELL_UP	CHPF2 TBC1D4 MUC4 ITGB2	4.10e-04	199	46	4	M6375
Coexpression	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN	COL6A3 ADAM23 ITGB2 EPAS1	4.10e-04	199	46	4	M3440
Coexpression	GSE32986_UNSTIM_VS_GMCSF_STIM_DC_DN	SDE2 ADAM23 AGRN OASL	4.10e-04	199	46	4	M8641
Coexpression	GSE17721_12H_VS_24H_CPG_BMDC_UP	FAM20C MUC4 DNMT3A PEAR1	4.10e-04	199	46	4	M4132
Coexpression	GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP	ESM1 ITGB2 EPAS1 SUMF1	4.10e-04	199	46	4	M5769
Coexpression	GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_DN	LRP1 NTN4 EPAS1 OASL	4.18e-04	200	46	4	M6270
Coexpression	GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP	ESM1 KAT2B PDZD2 OASL	4.18e-04	200	46	4	M8972
Coexpression	GSE43955_1H_VS_10H_ACT_CD4_TCELL_DN	COL6A3 PRSS8 ITGB7 NOTCH3	4.18e-04	200	46	4	M9659
Coexpression	GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN	FAM20C SDE2 ADAM23 AGRN	4.18e-04	200	46	4	M8635
Coexpression	GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_DN	NSD1 TMEM30B PLCG1 CELSR3	4.18e-04	200	46	4	M3914
Coexpression	LEE_AGING_NEOCORTEX_UP	LAMB1 OXT AVP	4.21e-04	83	46	3	MM1022
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HPERIC	LRP1 LAMA2 LAMB1 AGRN EPAS1 NOTCH3 PDZD2	4.39e-04	795	46	7	M39050
Coexpression	ZENG_GU_POST_ICB_METAGENE_31	ITGB2 ITGB7 ZNF513 OASL	4.93e-04	209	46	4	MM17088
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200	LRP1 LAMA2 EGFLAM ADAM23	3.25e-05	82	47	4	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500	LRP1 LAMA2 COL6A3 EGFLAM ADAM23	5.02e-05	182	47	5	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	LAMA2 LAMB1 COL6A3 EGFLAM PDZD2	6.31e-05	191	47	5	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LAMA2 LAMB1 COL6A3 EGFLAM NOTCH3 PEAR1 PDZD2	1.17e-09	190	47	7	2ab604d35456beba71c25511e0f819000e6642d2
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA2 LAMB1 TMEM30B EGFLAM EPAS1 NOTCH3 PEAR1	1.45e-09	196	47	7	cb61757646653f89faba503cb5d99e5dd5197b4c
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA2 LAMB1 TMEM30B EGFLAM EPAS1 NOTCH3 PEAR1	1.45e-09	196	47	7	44e2df1b61e3819eae7e482bef0a733afe852d67
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRP1 LAMA2 COL6A3 EPAS1 NOTCH3 PEAR1	3.65e-08	181	47	6	a2058d658f07ab6f0a28d2622f3090b4cde6f763
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRP1 LAMA2 COL6A3 EPAS1 NOTCH3 PEAR1	3.65e-08	181	47	6	526e858a848470b6d2d5248788004d9735ed3add
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LAMB1 EGFLAM EPAS1 NOTCH3 PEAR1 PDZD2	4.58e-08	188	47	6	ccddc08121caff958a2b6f9e278a018858af6b4d
ToppCell	E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LAMA2 LAMB1 EGFLAM NOTCH3 PEAR1 PDZD2	4.72e-08	189	47	6	26cfe5b7e7f477f225f4e9f25f983f432f01e183
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	LAMA2 LAMB1 COL6A3 EGFLAM NOTCH3 PEAR1	4.72e-08	189	47	6	d7ed96add29f219183c802895fbff519b627f635
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA2 LAMB1 EGFLAM NOTCH3 PEAR1 PDZD2	4.72e-08	189	47	6	ca3a04c202afc32aa11d17154066ef7dc6d01405
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA2 LAMB1 EGFLAM NOTCH3 PEAR1 PDZD2	4.87e-08	190	47	6	7e4d80a3a7f83b6a50f1d0fe82fb6c242c39d5b0
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA2 LAMB1 EGFLAM NOTCH3 PEAR1 PDZD2	4.87e-08	190	47	6	1004e89d99c9d46c78b7d3532d8d4aadb81a96fd
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA2 LAMB1 EGFLAM NOTCH3 PEAR1 PDZD2	4.87e-08	190	47	6	951e067d14412db67dc3babcdf61e41717d7b429
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LAMA2 LAMB1 EGFLAM NOTCH3 PEAR1 PDZD2	4.87e-08	190	47	6	979b1476fd2692fde977ce56257315fcfc8a01d5
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA2 LAMB1 EGFLAM NOTCH3 PEAR1 PDZD2	4.87e-08	190	47	6	7fec459cd2ad12c2923a03d098289337c0a4c1d3
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA2 LAMB1 EGFLAM NOTCH3 PEAR1 PDZD2	4.87e-08	190	47	6	10b02c62e72bfea9767e3e751011436925da823e
ToppCell	E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL6A3 EGFLAM EPAS1 NOTCH3 PEAR1 PDZD2	4.87e-08	190	47	6	84fbd5664ec886120963d4f50dfa1fd1851d36c1
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LAMA2 LAMB1 EGFLAM NOTCH3 PEAR1 PDZD2	5.03e-08	191	47	6	ddbc5f97f2aef19be4ad93db4139876c939b848e
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LAMA2 LAMB1 EGFLAM NOTCH3 PEAR1 PDZD2	5.03e-08	191	47	6	2ad717b59215ad8d933e9637d363b65d7298e5d4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA2 LAMB1 EGFLAM EPAS1 NOTCH3 PEAR1	5.18e-08	192	47	6	09cb5b89a164ac7444774ccc8c90323c8ea2026b
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LAMA2 LAMB1 EGFLAM NOTCH3 PEAR1 PDZD2	5.18e-08	192	47	6	063e119c4b58957643908f667e6cfd6f7517fd03
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA2 LAMB1 EGFLAM NOTCH3 PEAR1 PDZD2	5.18e-08	192	47	6	158cc5736f154da1cb3186ffbf186eae10483e48
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA2 LAMB1 EGFLAM NOTCH3 PEAR1 PDZD2	5.18e-08	192	47	6	f4ff62ac9c53eafbe917706de9af8b2d4bded4d4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA2 LAMB1 EGFLAM EPAS1 NOTCH3 PEAR1	5.35e-08	193	47	6	dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA2 LAMB1 EGFLAM EPAS1 NOTCH3 PEAR1	5.35e-08	193	47	6	2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA2 LAMB1 NTN4 NOTCH3 PEAR1 PDZD2	5.68e-08	195	47	6	4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA2 LAMB1 NTN4 NOTCH3 PEAR1 PDZD2	5.68e-08	195	47	6	7a32a8535c29b819dacba901d0658280a2631c94
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL6A3 EGFLAM AGRN EPAS1 NOTCH3 PEAR1	5.86e-08	196	47	6	7acd782a587b7d331517f60daa8b5c2177bedfc7
ToppCell	PND28-Mesenchymal\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LRP1 LAMA2 LAMB1 COL6A3 NOTCH3 PDZD2	5.86e-08	196	47	6	119265efd2219f328d8152dbee52af8327aec89c
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL6A3 EGFLAM AGRN EPAS1 NOTCH3 PEAR1	6.04e-08	197	47	6	983502a99e6d59bb36225b0246a9990604de1a01
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	LAMA2 LAMB1 COL6A3 EGFLAM NOTCH3 PDZD2	6.04e-08	197	47	6	44cd1ece3633a31e8c9b667cd3cbc2749c06f478
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Pericyte\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	LAMB1 COL6A3 EGFLAM EPAS1 NOTCH3 PDZD2	6.22e-08	198	47	6	72aad5b2dcd8b0bde58828fa4f8129fe6cb6a21d
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	LAMB1 COL6A3 EGFLAM EPAS1 NOTCH3 PDZD2	6.22e-08	198	47	6	76d46950c11cb4708866db0da54ce00d5c0adab8
ToppCell	distal-3-mesenchymal-Pericyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LAMA2 LAMB1 COL6A3 EGFLAM NOTCH3 PEAR1	6.60e-08	200	47	6	911db29f254bb697610e720ba78816e2c7f57933
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	LRP1 LAMA2 LAMB1 COL6A3 NOTCH3 PDZD2	6.60e-08	200	47	6	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA2 LAMB1 EGFLAM NOTCH3 PDZD2	7.49e-07	161	47	5	82ed45f144a07856fe92d37426c5f92e259a03a9
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	LAMA2 LAMB1 COL6A3 EGFLAM NOTCH3	1.01e-06	171	47	5	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA2 LAMB1 EGFLAM NOTCH3 PDZD2	1.07e-06	173	47	5	f9d6e892d66f9b94e4d5beb9f5dec9b606bc868a
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA2 LAMB1 EGFLAM NOTCH3 PDZD2	1.07e-06	173	47	5	cbd65dd5b01cc959e3ccbc89330ddd0122296ea3
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 EGFLAM AGRN EPAS1 NOTCH3	1.23e-06	178	47	5	e5e4742e35c3d90f82b830d77bdbdc45828c7deb
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAMA2 LAMB1 EGFLAM NOTCH3 PDZD2	1.26e-06	179	47	5	f5bb4d3a27d56698473219970e764084096cc582
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAMA2 LAMB1 EGFLAM NOTCH3 PDZD2	1.26e-06	179	47	5	fa03ec3cc0132f977b4cb28e7b23789732375183
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA2 LAMB1 EGFLAM NOTCH3 PDZD2	1.26e-06	179	47	5	56db12467b445f2b8ef92af50779eeab10413eb2
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA2 LAMB1 EGFLAM EPAS1 NOTCH3	1.30e-06	180	47	5	64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 LAMB1 EGFLAM NOTCH3 PDZD2	1.30e-06	180	47	5	f6a05b3751b01e74b2de8440801b0eb2e723c199
ToppCell	droplet-Lung-nan-18m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 LAMB1 EGFLAM NOTCH3 PDZD2	1.30e-06	180	47	5	dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA2 EGFLAM EPAS1 NOTCH3 PEAR1	1.37e-06	182	47	5	fc4a5bf784705efe7965ce43ac23c2a8e602e90a
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|tumor_Lung / Location, Cell class and cell subclass	LAMB1 COL6A3 EGFLAM NOTCH3 PEAR1	1.41e-06	183	47	5	a03dd563af9b15cb1f5de5732a229405a9f82d84
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LAMA2 LAMB1 EGFLAM NOTCH3 PDZD2	1.45e-06	184	47	5	327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b
ToppCell	LA-07._Pericyte\|LA / Chamber and Cluster_Paper	EGFLAM EPAS1 NOTCH3 PEAR1 PDZD2	1.48e-06	185	47	5	ba5baa4d7f097108622674de5b7f4fd279843d24
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA2 LAMB1 NOTCH3 PEAR1 PDZD2	1.52e-06	186	47	5	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	RV-07._Pericyte\|RV / Chamber and Cluster_Paper	EGFLAM EPAS1 NOTCH3 PEAR1 PDZD2	1.52e-06	186	47	5	c533b264fbe12bc35467486fc7fbde24ba968fe1
ToppCell	RV-07._Pericyte\|World / Chamber and Cluster_Paper	EGFLAM EPAS1 NOTCH3 PEAR1 PDZD2	1.57e-06	187	47	5	dc274d6bbda619a2c914d84e2b4069cfef1739d1
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA2 LAMB1 NOTCH3 PEAR1 PDZD2	1.61e-06	188	47	5	a906c29e3fda22eecfec3e5cac706c417bf2b7a4
ToppCell	P28-Mesenchymal-developing_mesenchymal_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LAMB1 EGFLAM NOTCH3 PEAR1 PDZD2	1.61e-06	188	47	5	e7681efb4d2de7f1d8a89552fff76a829376bf1b
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1 LAMA2 COL6A3 EGFLAM ADAM23	1.65e-06	189	47	5	544d95df910f1b276995624509a7e41b219baca0
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA2 LAMB1 NOTCH3 PEAR1 PDZD2	1.69e-06	190	47	5	106862ef44fcaa0971c3ba0147d13eb08015ca77
ToppCell	facs-Heart-LV-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMA2 LAMB1 COL6A3 EGFLAM NOTCH3	1.74e-06	191	47	5	b7a57691a4742070cee640e285c1f4d0da95baf1
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LAMA2 LAMB1 COL6A3 EGFLAM ADAM23	1.78e-06	192	47	5	1b228f0929b505de82a39bf64c837887b0e56701
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	LRP1 LAMA2 LAMB1 COL6A3 EPAS1	1.78e-06	192	47	5	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	IPF-Stromal-Pericyte\|Stromal / Disease state, Lineage and Cell class	EGFLAM EPAS1 NOTCH3 PEAR1 PDZD2	1.87e-06	194	47	5	3892b188f424ffb80f3c75a1b6709a21c1e1601d
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 EGFLAM AGRN EPAS1 NOTCH3	1.87e-06	194	47	5	7a7406c3b021aeafde423d20290c681c3e8ea0a6
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TMEM30B EGFLAM AGRN NOTCH3 PEAR1	1.87e-06	194	47	5	a7731378f44ca1a229311686caf5740c742d21ba
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 EGFLAM AGRN EPAS1 NOTCH3	1.92e-06	195	47	5	815ac5dacd382b11abb32011ed1c0635b0ddc779
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 EGFLAM AGRN EPAS1 NOTCH3	1.92e-06	195	47	5	9b3fa1d42ec5aa2911f27a99cd8b57714c6bd604
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMB1 EGFLAM EPAS1 NOTCH3 PEAR1	1.92e-06	195	47	5	d760d1423f9a8a373fe7b250ea9b1d67a0c0059f
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL6A3 EGFLAM AGRN NOTCH3 PEAR1	1.97e-06	196	47	5	40e6900a0d56088a40d37ec312f53207ea952602
ToppCell	cellseq-Mesenchymal-Myocytic-Myocytic_1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LAMA2 LAMB1 COL6A3 NOTCH3 PEAR1	1.97e-06	196	47	5	c373465e34e2dd581247962d59e0477aae877079
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 EGFLAM AGRN EPAS1 NOTCH3	1.97e-06	196	47	5	c16fbd23d9e117831b55ab3da5b08b22dd972432
ToppCell	IPF-Stromal-Pericyte\|IPF / Disease state, Lineage and Cell class	LAMB1 COL6A3 EGFLAM NOTCH3 PEAR1	1.97e-06	196	47	5	8b6ff47ce5291d223f5e639fc45cd9267f418256
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA2 AGRN EPAS1 NOTCH3 PEAR1	1.97e-06	196	47	5	12d9028f90c057c6e5cff00301793fa550e86c5a
ToppCell	cellseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LAMA2 LAMB1 COL6A3 NOTCH3 PEAR1	1.97e-06	196	47	5	8b5337ccf74de90e8b89a02ac00671af1de2cfff
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL6A3 EGFLAM AGRN NOTCH3 PEAR1	1.97e-06	196	47	5	0b247cf981981ae61aca5de82ef687e8d783c9ef
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA2 NTN4 NOTCH3 PEAR1 PDZD2	1.97e-06	196	47	5	6708026bafd19c35c5c4e81911344d36a0f508cd
ToppCell	Tracheal-10x5prime-Stromal-Peri/Epineurial_\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LRP1 LAMA2 LAMB1 EGFLAM PEAR1	2.02e-06	197	47	5	2cb1f557ce1400398975de94638126b4522567f3
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL6A3 EGFLAM AGRN NOTCH3 PEAR1	2.02e-06	197	47	5	af819b0561c8db582c5b466d804153d69d3297e0
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	LAMA2 LAMB1 NTN4 GSG1L NOTCH3	2.07e-06	198	47	5	55e583321f60c95898d93cd0d2615c6692db52ec
ToppCell	Non-neuronal-Postmitotic-Mural-Mural\|World / Primary Cells by Cluster	LAMA2 ESM1 AGRN EPAS1 NOTCH3	2.07e-06	198	47	5	9fc1035ea447a4551a66944c869c4671e17cec61
ToppCell	Non-neuronal-Postmitotic-Mural\|World / Primary Cells by Cluster	LAMA2 ESM1 AGRN EPAS1 NOTCH3	2.07e-06	198	47	5	dd38840a96171f58da243daa22b013e15a81db4a
ToppCell	Non-neuronal-Postmitotic-Mural-Mural-18\|World / Primary Cells by Cluster	LAMA2 ESM1 AGRN EPAS1 NOTCH3	2.07e-06	198	47	5	21efb7bcd24f24d20791b34e75d6f9d46a129481
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	LAMA2 LAMB1 NTN4 GSG1L NOTCH3	2.12e-06	199	47	5	e19b296d583f8bad3b66ee998a8153634d6fe09e
ToppCell	10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	LAMB1 ESM1 COL6A3 NOTCH3 ZDHHC22	2.12e-06	199	47	5	6200618e029063486719479c41eaf31798bd13cf
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Pericyte\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NTN4 EGFLAM EPAS1 NOTCH3 PEAR1	2.12e-06	199	47	5	bd9b36dcf61eaa628ce1b70d21c5783b64c29e8f
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMB1 ESM1 AGRN EPAS1 PEAR1	2.12e-06	199	47	5	0602e2b2aa56d106da63bd342a38bef437b4d496
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NTN4 EGFLAM EPAS1 NOTCH3 PEAR1	2.12e-06	199	47	5	e751eb67510f8a5842dcfed44134160919cdb713
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	LAMA2 LAMB1 NTN4 GSG1L NOTCH3	2.12e-06	199	47	5	801887db51ac5dc5b068808ff75e3a46643398e9
ToppCell	proximal-3-mesenchymal-Pericyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LAMA2 LAMB1 COL6A3 NOTCH3 PEAR1	2.18e-06	200	47	5	98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	LAMA2 LAMB1 NOTCH3 PEAR1 PDZD2	2.18e-06	200	47	5	0c648941447c738caf62f2d71e296d6cca492c8b
ToppCell	Control_saline-Mesenchymal_myocytic\|Control_saline / Treatment groups by lineage, cell group, cell type	LRP1 LAMA2 LAMB1 COL6A3 NOTCH3	2.18e-06	200	47	5	5ed4261157cd51109b314818133ac3a0d34ee5fa
ToppCell	Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-1\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	LAMB1 COL6A3 EGFLAM NOTCH3 PEAR1	2.18e-06	200	47	5	78e9a40153d7ba5d9ea6393a37d26fc5c0220867
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LAMA2 LAMB1 NOTCH3 PEAR1 PDZD2	2.18e-06	200	47	5	522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCell	COVID-19-Fibroblasts-Vascular_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	LAMB1 ESM1 COL6A3 EPAS1 NOTCH3	2.18e-06	200	47	5	c7f82196a0768ad96b1df8b8915bc541fb118a76
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	LAMB1 COL6A3 EGFLAM NOTCH3 PEAR1	2.18e-06	200	47	5	c46e06b4f22d3456e67bc62a9ac198e8041965ad
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LAMB1 COL6A3 EGFLAM NOTCH3 PEAR1	2.18e-06	200	47	5	43b76e382b38b9856c07557a75e5b1ce0cee1d9e
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	LAMA2 LAMB1 NOTCH3 PEAR1 PDZD2	2.18e-06	200	47	5	94f1fa61aa82eb9f411b2b1cb759476939ab5db7
ToppCell	Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA2 LAMB1 COL6A3 EGFLAM NOTCH3	2.18e-06	200	47	5	f9bc22ff17bb1c751e6b05bca3f403836f33459a
ToppCell	proximal-mesenchymal-Pericyte\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LAMA2 LAMB1 COL6A3 NOTCH3 PEAR1	2.18e-06	200	47	5	03119a979bc912a98e6fc87addcbc25d8ecf2fb0
ToppCell	Parenchymal-10x5prime-Stromal-Pericyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA2 LAMB1 COL6A3 EGFLAM NOTCH3	2.18e-06	200	47	5	0a7640db28c708003d5da2d19eb651f6fedfd710
ToppCell	proximal-mesenchymal-Pericyte-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LAMA2 LAMB1 COL6A3 NOTCH3 PEAR1	2.18e-06	200	47	5	a81fde3d40b8efb3be535aeb2a44cfbdeb17bc8b
ToppCell	frontal_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	EGFLAM EPAS1 NOTCH3 PEAR1	8.39e-06	122	47	4	c16110934172f174f4aefe14b81abce8514b30f0
ToppCell	frontal_cortex-Non-neuronal-pericyte_cell-Peri\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	EGFLAM EPAS1 NOTCH3 PEAR1	8.39e-06	122	47	4	006ac4f6807e688554d36557d29d5e5a0bc3c36f
Computational	Adhesion molecules.	LAMA2 LAMB1 COL6A3 ITGB2 ITGB7	2.31e-05	141	27	5	MODULE_122
Computational	Trachea genes.	LRP1 COL6A3 PRSS8 MUC4 EPAS1 NOTCH3 TFF1	5.52e-05	415	27	7	MODULE_6
Computational	Developmental processes.	LAMA2 COL6A3 ADAM23 ITGB2 ITGB7 EPAS1	1.44e-04	333	27	6	MODULE_220
Computational	Genes in the cancer module 275.	ITGB2 ITGB7	7.13e-04	16	27	2	MODULE_275
Drug	NSC19448	COL6A3 OXT AVP ITGB7 TFF1 DNMT3A PDZD2	1.18e-06	273	46	7	CID000003054
Drug	Demoxytocin	OXT AVP	3.99e-06	2	46	2	CID000008229
Drug	AC1NURZQ	OXT AVP	3.99e-06	2	46	2	CID005490952
Drug	P9-28	OXT AVP	3.99e-06	2	46	2	CID000139428
Drug	Pro-arg-gly-amide	OXT AVP	3.99e-06	2	46	2	CID000170777
Drug	2-phenylalanine	OXT AVP	3.99e-06	2	46	2	CID000031722
Drug	Phasvatocin	OXT AVP	3.99e-06	2	46	2	CID000192334
Drug	ethyl cyclohexylideneacetate	OXT AVP	3.99e-06	2	46	2	CID000073776
Drug	Cgp 29325	OXT AVP	3.99e-06	2	46	2	CID000175772
Drug	Glumitocin	OXT AVP	3.99e-06	2	46	2	CID003084054
Drug	LMWH	LRP1 LAMA2 LAMB1 COL6A3 CHPF2 OXT AVP AGRN SUMF1	5.99e-06	663	46	9	CID000000772
Drug	Betamethasone-d5	LRP1 LAMA2 LAMB1 PRSS8 TBC1D4 OXT CLPX AVP ITGB2 ITGB7 TFF1 PDZD2	9.86e-06	1340	46	12	CID000003003
Drug	AC1O4Q3H	OXT AVP	1.20e-05	3	46	2	CID006410744
Drug	ranatensin C	OXT AVP	1.20e-05	3	46	2	CID005488559
Drug	Annetocin	OXT AVP	1.20e-05	3	46	2	CID000197651
Drug	L 366811	OXT AVP	1.20e-05	3	46	2	CID003083084
Drug	dE-Vvt	OXT AVP	1.20e-05	3	46	2	CID003083171
Drug	AC1L45X9	OXT AVP	1.20e-05	3	46	2	CID000151233
Drug	L 366682	OXT AVP	1.20e-05	3	46	2	CID000196819
Drug	Dglvp	OXT AVP	1.20e-05	3	46	2	CID000169434
Drug	Asvatocin	OXT AVP	1.20e-05	3	46	2	CID000192333
Drug	5-Ctydu	NSD1 OXT	2.39e-05	4	46	2	CID000126106
Drug	Phenypressin	OXT AVP	2.39e-05	4	46	2	CID003082314
Drug	Pressinamide	OXT AVP	2.39e-05	4	46	2	CID003082272
Drug	Dpvdavp	OXT AVP	2.39e-05	4	46	2	CID003081540
Drug	Vasotocin	OXT AVP	2.39e-05	4	46	2	ctd:D014668
Drug	Z-PLG	OXT AVP	2.39e-05	4	46	2	CID000151917
Drug	Conopressin G	OXT AVP	2.39e-05	4	46	2	CID000163847
Drug	Mpomeovt	OXT AVP	3.98e-05	5	46	2	CID000122244
Drug	Tgot	OXT AVP	3.98e-05	5	46	2	CID003082106
Drug	AGN 190851	OXT AVP	3.98e-05	5	46	2	CID000131829
Drug	L 365209	OXT AVP	3.98e-05	5	46	2	CID000196774
Drug	Felypressin	OXT AVP	3.98e-05	5	46	2	CID000005956
Drug	Oligomycins	COL6A3 PLCG1 TBC1D4	4.04e-05	33	46	3	ctd:D009840
Drug	radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; PC3; HT_HG-U133A	PLCG1 CELSR3 AGRN NOTCH3 PDZD2	4.62e-05	196	46	5	4443_UP
Drug	Spironolactone [52-01-7]; Up 200; 9.6uM; PC3; HT_HG-U133A	PPP1R3D CELSR3 AVP ADAM23 DNMT3A	4.62e-05	196	46	5	5781_UP
Drug	Idazoxan hydrochloride [79944-56-2]; Down 200; 16.6uM; PC3; HT_HG-U133A	PPP1R3D CELSR3 ADAM23 ITGB2 EPAS1	4.74e-05	197	46	5	6747_DN
Drug	Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A	PPP1R3D PRSS8 PLCG1 ITGB2 NOTCH3	4.85e-05	198	46	5	4550_DN
Drug	Prednisolone [50-24-8]; Down 200; 11uM; MCF7; HT_HG-U133A	NSD1 PPP1R3D LAMB1 PLCG1 CELSR3	4.85e-05	198	46	5	5526_DN
Drug	Etanidazole [22668-01-5]; Down 200; 18.6uM; MCF7; HT_HG-U133A	PPP1R3D LAMB1 PLCG1 CELSR3 NOTCH3	4.85e-05	198	46	5	6211_DN
Drug	panobinostat	LAMA2 PPP1R3D TMEM30B NTN4 COL6A3 KAT2B PRSS8 KISS1R FEZF2 MUC4 EPAS1	5.30e-05	1333	46	11	ctd:C496932
Drug	L-366,509	OXT AVP	5.96e-05	6	46	2	CID003083288
Drug	5-methoxy-N-isobutanoyltryptamine	OXT AVP	5.96e-05	6	46	2	CID006455231
Drug	L-371,257	OXT AVP	5.96e-05	6	46	2	CID006918320
Drug	D3PVP	OXT AVP	5.96e-05	6	46	2	CID000195824
Drug	oxypressin	OXT AVP	5.96e-05	6	46	2	CID000164712
Drug	Deavp	OXT AVP	5.96e-05	6	46	2	CID000114715
Drug	Cosopt	LAMA2 ESM1 NTN4 AVP ITGB2 AGRN	6.11e-05	341	46	6	CID000003154
Drug	OPC-31260	PKHD1 OXT AVP	6.20e-05	38	46	3	CID000119369
Drug	IEM-611	OXT AVP	8.33e-05	7	46	2	CID000039794
Drug	B3852	OXT AVP	8.33e-05	7	46	2	CID000086074
Drug	Vdavp	OXT AVP	8.33e-05	7	46	2	CID000171113
Drug	AC1O1J2W	OXT MUC4 TFF1	9.65e-05	44	46	3	CID006122347
Drug	L 366948	OXT AVP	1.11e-04	8	46	2	CID000188397
Drug	colchine	LAMA2 LAMB1 COL6A3 OXT AVP PDZD2	1.16e-04	383	46	6	CID000002833
Drug	Lypressin	PLCG1 OXT AVP	1.18e-04	47	46	3	CID000005772
Drug	bisindolylmaleimide I	PLCG1 AVP ITGB2 TFF1	1.42e-04	131	46	4	ctd:C070515
Drug	Cp 14	OXT AVP	1.42e-04	9	46	2	CID005487244
Drug	AC1MIZWH	OXT AVP	1.42e-04	9	46	2	CID003083001
Drug	pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid	OXT AVP	1.42e-04	9	46	2	ctd:C077792
Drug	d(CH2)5-Davp	OXT AVP	1.42e-04	9	46	2	CID000123750
Drug	Mcp-tva-argipressin	OXT AVP	1.42e-04	9	46	2	CID000122322
Drug	Hydrin 1	OXT AVP	1.42e-04	9	46	2	CID000195374
Drug	Duratocin	OXT AVP	1.78e-04	10	46	2	CID000071715
Drug	JTP 4819	OXT AVP	1.78e-04	10	46	2	ctd:C094211
Drug	cyclo(Leu-Gly)	OXT AVP	1.78e-04	10	46	2	CID000002902
Drug	NSC-86924	OXT ITGB2	1.78e-04	10	46	2	CID005357766
Drug	AC1MIWZV	OXT AVP	1.78e-04	10	46	2	CID003081474
Drug	2,4-diaminopyrimidine	NSD1 LAMB1 AGRN	1.78e-04	54	46	3	CID000067431
Drug	AC1L1G72	LAMA2 LAMB1	2.17e-04	11	46	2	CID000003553
Drug	Dpmetyravp	OXT AVP	2.17e-04	11	46	2	CID000119517
Drug	LG 5	LAMA2 LAMB1 AGRN	2.44e-04	60	46	3	CID011840957
Drug	AC1L24WE	PKHD1 AVP EPAS1	2.56e-04	61	46	3	CID000014977
Drug	1-adamantaneacetic acid	OXT AVP	2.60e-04	12	46	2	CID000123221
Drug	Prazosin	PLCG1 OXT AVP	2.82e-04	63	46	3	ctd:D011224
Drug	AC1MIYR4	OXT AVP	3.07e-04	13	46	2	CID003082393
Drug	genistein	LAMA2 LAMB1 COL6A3 KAT2B PLCG1 OXT ITGB2 ITGB7 TFF1	3.40e-04	1117	46	9	CID005280961
Drug	Apgw-amide	OXT FEZF2	3.58e-04	14	46	2	CID000122223
Drug	2-thiazolylethylamine	OXT AVP	3.58e-04	14	46	2	CID000087653
Drug	Ovta	OXT AVP	3.58e-04	14	46	2	CID003081047
Drug	AC1NFF1B	OXT AVP	3.58e-04	14	46	2	CID004657542
Drug	Dicarbethoxydihydrocollidine	KAT2B DNMT3A	3.58e-04	14	46	2	ctd:D003997
Drug	Utedrin	OXT AVP	3.58e-04	14	46	2	CID000005771
Drug	paramethoxyphenyl-acetyl dehydroalanine	LRP1 ITGB2 TFF1	3.68e-04	69	46	3	CID000130300
Drug	flurbiprofen	LRP1 AVP NOTCH3 TFF1	3.92e-04	171	46	4	CID000003394
Drug	sulprostone	PLCG1 OXT AVP	4.01e-04	71	46	3	CID005312153
Drug	dysprosium	LAMA2 LAMB1 AGRN	4.53e-04	74	46	3	CID000023912
Drug	ginsenoside Rh1	ITGB2 TFF1	4.71e-04	16	46	2	ctd:C425564
Drug	Dynorphin (1-8)	OXT AVP	4.71e-04	16	46	2	CID000108135
Drug	BAPTA	PLCG1 KISS1R OXT AVP AGRN	4.81e-04	324	46	5	CID000104751
Drug	prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A	PLCG1 EPAS1 TFF1 OASL	5.06e-04	183	46	4	6547_UP
Drug	2-amino-5-methylpyridine	LAMA2 LAMB1 AGRN	5.08e-04	77	46	3	CID000015348
Drug	atosiban	OXT AVP	5.33e-04	17	46	2	CID000068613
Drug	Fadrozole	KISS1R TFF1	5.33e-04	17	46	2	ctd:D017316
Drug	butylphen	LRP1 TFF1	5.33e-04	17	46	2	ctd:C006862
Drug	N-methyl-DL-alanine	OXT AVP	5.33e-04	17	46	2	CID000004377
Drug	alpha-Chlorohydrin	LRP1 TMEM30B ESM1 CLPX ADAM23 ITGB2 AGRN MMD2	5.33e-04	941	46	8	ctd:D000517
Drug	YIGSR	LAMA2 LAMB1 NTN4	5.48e-04	79	46	3	CID000123977
Drug	Mometasone furoate [83919-23-7]; Up 200; 7.6uM; PC3; HT_HG-U133A	PLCG1 MUC4 ITGB7 EPAS1	5.49e-04	187	46	4	5116_UP
Drug	Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; PC3; HT_HG-U133A	LRP1 AGRN EPAS1 DNMT3A	5.72e-04	189	46	4	4308_UP
Disease	Dysmenorrhea	OXT AVP	2.27e-06	2	45	2	C0013390
Disease	Hyponatremia	OXT AVP	1.36e-05	4	45	2	C0020625
Disease	Polyuria	OXT AVP	2.27e-05	5	45	2	C0032617
Disease	oxytocin-neurophysin 1 measurement	OXT AVP	3.40e-05	6	45	2	EFO_0802839
Disease	Migraine Disorders	LRP1 NOTCH3	1.76e-04	13	45	2	C0149931
Disease	optic disc size measurement	GSX2 KAT2B FEZF2 PDZD2	2.70e-04	205	45	4	EFO_0004832
Disease	muscular dystrophy (is_implicated_in)	LAMA2 COL6A3	3.05e-04	17	45	2	DOID:9884 (is_implicated_in)
Disease	red blood cell density measurement	PKHD1 ASB16-AS1 KAT2B TBC1D4 MUC4 DNMT3A PEAR1	3.46e-04	880	45	7	EFO_0007978
Disease	Granulomatous Slack Skin	PLCG1 DNMT3A	5.15e-04	22	45	2	C0376407
Disease	Lymphoma, T-Cell, Cutaneous	PLCG1 DNMT3A	5.64e-04	23	45	2	C0079773
Disease	severe acute respiratory syndrome, COVID-19	NTN4 COL6A3 GSG1L ADAM23 PDZD2	5.79e-04	447	45	5	EFO_0000694, MONDO_0100096
Disease	Autistic Disorder	NSD1 LAMB1 OXT AVP	6.70e-04	261	45	4	C0004352
Disease	cancer (implicated_via_orthology)	ITGB2 ITGB7 EPAS1 NOTCH3	7.40e-04	268	45	4	DOID:162 (implicated_via_orthology)
Disease	Sezary Syndrome	PLCG1 DNMT3A	7.79e-04	27	45	2	C0036920
Disease	Ischemia	OXT AVP	8.38e-04	28	45	2	C0022116
Disease	Acute Myeloid Leukemia, M1	NSD1 AGRN DNMT3A	9.25e-04	125	45	3	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	NSD1 AGRN DNMT3A	9.25e-04	125	45	3	C1879321

Protein segments in the cluster

Peptide	Gene	Start	Entry
AGSKASLPPCCGQAS	EPAS1	611	Q99814
ARPADCVLCPNKGGA	BRD1	266	O95696
APCAHGGSCRPRKEG	EGFLAM	791	Q63HQ2
CSLAGASCGPQRGPA	ADAM23	16	O75077
SGKGGNQLRCPKCGD	CLPX	96	O76031
CCTPKEGRGAPAEAG	DNMT3A	136	Q9Y6K1
KPGCGQGGRANCPNS	GSG1L	41	Q6UXU4
GVAGPKCGQCPDGRA	AGRN	871	O00468
KCGQCPDGRALGPAG	AGRN	876	O00468
KRCAAACGACARPPG	ASB16-AS1	71	Q495Z4
KCGAPNCSGFLGVRP	NSD1	2071	Q96L73
GKGCEACPPNLTGDG	MUC4	5091	Q99102
GEACPKAGTACLPAR	MMD2	166	Q8IY49
PCAAAAGGSGACGPA	KAT2B	41	Q92831
GPVCTCPNGKRLDNG	LRP1	4166	Q07954
SGPGCPSRKSGAFCV	GSX2	46	Q9BZM3
AGGVSCPEKGGNRAC	PDZD2	2526	O15018
CPEKGGNRACPGGSG	PDZD2	2531	O15018
QLPCPKGQFGEGCAS	PEAR1	521	Q5VY43
GSPCANGGRCTQLPS	NOTCH3	46	Q9UM47
PANASGCPGCGANAS	KISS1R	16	Q969F8
KSCACNPLGTIPGGN	LAMB1	456	P07942
CSGLGSKNEDPCFGP	LAMA2	471	P24043
GCRAPNGTGPLCSGK	ITGB7	526	P26010
SLIKACGGPGNFCPS	OASL	176	Q15646
KGPFGKNCSAACPGL	ITGB2	636	P05107
RGARPSGEPGCSCAQ	FAM20C	36	Q8IXL6
GVPCKCSGQRGDRGP	COL6A3	2031	P12111
CSVCAAAGQGRALPP	TMEM30B	76	Q3MIR4
KCGPGLRCQPSNGED	ESM1	76	Q9NQ30
KAGPCEQAGSPCRNG	DLK2	131	Q6UY11
PGVCRNGGTCTDAPN	CELSR3	1481	Q9NYQ7
RGPGFGCKAVRCASG	SDE2	11	Q6IQ49
GGAPVCGASGLCKTN	FEZF2	116	Q8TBJ5
SNGDCPCKPGVAGRR	NTN4	416	Q9HB63
LPSPCQSGQKACGSG	OXT	81	P01178
SPGNVSAAVCGAPCR	PKHD1	1761	P08F94
KDACQGDSGGPLSCP	PRSS8	231	Q16651
LAGSCGCGTPQRPGA	SUMF1	46	Q8NBK3
CGFPGVTPSQCANKG	TFF1	41	P04155
CADGAPKCPLQGASR	CHPF2	386	Q9P2E5
GPQGPSDKGFACSLC	ZNF513	351	Q8N8E2
LGACQGASARKTPCP	ZDHHC22	76	Q8N966
GGGNAVACPVCRAPT	RNF225	101	M0QZC1
LPSPCQSGQKACGSG	AVP	81	P01185
MAGAASPCANGCGPG	PLCG1	1	P19174
AGAPGAACRPGCSQK	PPP1R3D	86	O95685
SQKPEAGGCGAPAAR	TBC1D4	66	O60343